Billionaire Seth Klarman’s Latest Stock Picks

BAUPOST GROUPThe Baupost Group, managed by Seth Klarman, filed its 13F with the SEC for the second quarter of 2012 this week. Klarman is a value investor known for writing Margin of Safety. According to Insider Monkey’s calculations, the fund moved heavily into stocks with a couple large new positions and several other top holdings from the previous quarter being increased. Here are some trends that we see in the Baupost Group’s portfolio for this quarter versus last quarter:

Large-cap value. Baupost added substantially to its positions in BP Plc (NYSE:BP) and Hewlett Packard (NYSE:HPQ). BP made our list of the ten most popular energy stocks among hedge funds for the first quarter and it’s easy to see why: because of poor sentiment, it trades at only eight times earnings even though the company pays a dividend yield of 4.5%; it’s easy to see why Klarman agrees with our judgment from last month that BP is an energy stock for long term investors. Hewlett-Packard has a smaller market capitalization of “only” $39 billion, but it too pays a good dividend yield for its industry- 2.7%- and yet still trades at eight times trailing earnings. HP is struggling as revenue and earnings fall, but as with BP Baupost appears to think that the stock has fallen from its fundamental value and we think they might be right.

Technology. We’ve covered HP already, which was a more than 50% increase in share count for the fund. Perhaps this move wasn’t motivated only by good valuation multiples but also by bullishness on technology, as Baupost initiated a 15.8 million share position in Oracle (NASDAQ:ORCL). The trailing P/E here is 16, which is only a moderate level in pure value terms, but Oracle recorded 8% earnings growth in its most recent quarter compared to the same period in the previous year and based on analyst estimates the forward P/E is only 10 and the five-year PEG is 1. This pick has to deliver growth in order to justify outperforming the market, and Klarman seems to agree with sell-side judgments that it will get there. Perhaps the fund is making specific statements about HP and Oracle, but it is also possible that this move is intended to build more exposure to technology.

Gold. Baupost increased its stake in Allied Nevada Gold (NYSE:ANV) from 4 million shares to 5.1 million, and added 6 million shares of NovaGold (NYSE:NG) for a total of 16 million in that stock. These represented some fairly large positions compared to the sizes of the companies- their market caps are only $2.4 billion and $1.2 billion respectively. Each has also seen its share price drop over the last year and is down over 30%. Allied Nevada is at least profitable, and is supposed to rebound in the future as its forward P/E is only 12, but NovaGold is not expected by sell-side analysts to generate positive earnings per share this year or next year. By increasing these positions Baupost appears to be committing to a gold thesis rather than evaluating these companies on historical performance as a signal of value.

Genworth. The fund took a large position of 15 million shares in Genworth Financial (NYSE:GNW). The insurance and wealth management company has dropped nearly 30% this year and has missed earnings for three quarters in a row. Perhaps Klarman thought the market had overreacted, and looking at valuation multiples it seems that there could be a value case here. Genworth trades at about a sixth of the book value of its equity and only four times forward earnings estimates. Even on a trailing basis the P/E is 7. Genworth isn’t a great company but the fund is likely snapping up the shares based in value.

Baupost’s movements here show a clear value focus. BP, HP, and Genworth are textbook value stocks with P/E ratios less than 10 and while they are troubled it’s easy to see them bouncing back. Oracle we’re not too sure about- it may be being bought on a cheap growth basis, but combined with HP it’s possible the fund is also pushing a tech thesis. And of course we’ve discussed gold as an area where Baupost appears to be taking a macro stance and even increasing its holdings of a currently unprofitable commodities-driven company by 60%. That’s probably the theme we’d least recommend to investors.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!